USA – Pfizer plans COVID-19 vaccine testing in children

Nearly a fifth of 11,000 people enrolled so far in a 30,000-volunteer U.S. trial testing a COVID-19 vaccine from Pfizer (PFE.N) and German partner BioNTech (22UAy.F) are Black or Latino, groups among the hardest hit by the coronavirus virus pandemic, a top Pfizer executive said.

“Between Latinx and Black or African American populations, we’re running at about 19 percent or so,” Dr. Bill Gruber, Pfizer’s senior vice president of vaccine clinical research and development, told Reuters in an interview.

“We’re trying to push even higher than that.”

Black and Latino Americans are infected with COVID-19 at more than twice the rate of white Americans, with Native Americans infected at even higher rates, research has shown. The groups are historically underrepresented in clinical trials.

The companies’ vaccine has quickly advanced into late-stage testing, with some participants already getting their second of two doses…